ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

Why INT033049 is on this study

  • The record lists it as a treatment, written “MGC026 Dose Escalation”.
  • A model not recorded judged it tested: part of what the study tests. Nov 1, 2026, 6:41 AM UTC
  • The role rule says the same.
  • So INT033049's page lists this study under “Testing it”.
20 links0 made here, not in the record23 judgments2 judges (the rules as one: Rule based)1 record change seen
Model not recordedRule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16Nov 23TodayNCT06242470A Study of MGC026 inParticipants With AdvancedSolid TumorsMacroGenicsPhase 1 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 28 · ClinicalTrials.gov record · Version of 2026-10-28Version of 2026-10-28CONDITIONSNeoplasm MetastasisThe registry's MeSH filing›Nov 14 · Rule based · General: a category, not a diseaseAs of now · Rule based · Main conditionMain conditionSquamous Cell Carcinoma of …The registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termCarcinoma, Non-Small-Cell L…The registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termSmall Cell Lung CarcinomaThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termUrinary Bladder NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termSarcomaThe registry's MeSH filing›Nov 14 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseEndometrial NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termMelanomaThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termProstatic Neoplasms, Castra…The registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termUterine Cervical NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termColorectal NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termStomach NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termPancreatic NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termCarcinoma, Renal CellThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termCarcinoma, HepatocellularThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termBreast NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termOvarian NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termEsophageal Squamous Cell Ca…The registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termDRUGSINT033049Entry “MGC026 Dose Escalation”, read …›Nov 1 · A model not recorded · TestedNov 18 · Rule based · TestedTestedPembrolizumabEntry “Pembrollizumab”, read by our n…›Nov 1 · A model not recorded · BackgroundNov 18 · Rule based · TestedBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

All judgments on this study

WhenLinkJudgeDecisionState
1 version of the record seen on ClinicalTrials.gov, Oct 28 · changes seen, not judgments
Nov 1INT033049A model not recordedTestedCurrent
Nov 1PembrolizumabA model not recordedBackgroundCurrent
Nov 14Neoplasm MetastasisRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 14Squamous Cell Carcinoma of Head and NeckRule based · condition-kind ruleFinest filed termCurrent
Nov 14Carcinoma, Non-Small-Cell LungRule based · condition-kind ruleFinest filed termCurrent
Nov 14Small Cell Lung CarcinomaRule based · condition-kind ruleFinest filed termCurrent
Nov 14Urinary Bladder NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14SarcomaRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 14Endometrial NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14MelanomaRule based · condition-kind ruleFinest filed termCurrent
Nov 14Prostatic Neoplasms, Castration-ResistantRule based · condition-kind ruleFinest filed termCurrent
Nov 14Uterine Cervical NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Colorectal NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Stomach NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Pancreatic NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Carcinoma, Renal CellRule based · condition-kind ruleFinest filed termCurrent
Nov 14Carcinoma, HepatocellularRule based · condition-kind ruleFinest filed termCurrent
Nov 14Breast NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Ovarian NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Esophageal Squamous Cell CarcinomaRule based · condition-kind ruleFinest filed termCurrent
Nov 18INT033049Rule based · role ruleTestedAgrees
Nov 18PembrolizumabRule based · role ruleTestedOverridden
As of nowNeoplasm MetastasisRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.